Form 8-K - Current report:
SEC Accession No. 0001104659-21-082596
Filing Date
2021-06-17
Accepted
2021-06-17 16:06:20
Documents
12
Period of Report
2021-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120000d1_8k.htm   iXBRL 8-K 25009
  Complete submission text file 0001104659-21-082596.txt   200595

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrns-20210616.xsd EX-101.SCH 3202
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20210616_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20210616_pre.xml EX-101.PRE 22721
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2120000d1_8k_htm.xml XML 3747
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 211024746
SIC: 2834 Pharmaceutical Preparations